From
TBD
To
TBD
MAP Congress 2025
Event Information
MAP Congress is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalised medicine. It is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.
The event is designed to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology will be discussing the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.
MAP Congress is the perfect opportunity for exhibitors to present their products and services to a global audience and to network with world-leading experts in the field. Join us and be part of the future of precision oncology.
Generated by OpenAI for BoothSquare
European Society for Medical Oncology (ESMO)